Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update — DNG00042

Dengue Virus Infection Clinical Trial

Official title:
A Cross-sectional Survey to Evaluate Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update

Status Completed

Clinical Trial Summary

The primary objective of the study is to evaluate the effectiveness of additional risk minimization measures material by assessing the knowledge and understanding of healthcare professionals regarding the key safety messages provided in the material. The secondary objective of the study is to evaluate if healthcare professionals know Dengvaxia product information, namely, age indication and contraindications.

Clinical Trial Description

The study is a cross-sectional Survey. Study data are collected through a questionnaire. ;

Study Design

Related Conditions & MeSH terms

Dengue Virus Infection

Clinical Trial Details

NCT number	NCT04170140
Study type	Observational
Source	Sanofi
Contact
Status	Completed
Phase
Start date	January 7, 2020
Completion date	March 5, 2020

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04486638` - Dengvaxia US Pregnancy Registry
	Completed	`NCT04023708` - Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy